Vivo Capital Fund IX, L.P., 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 984,112 shares at $15.19 ($13.1M) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Open-market sale of $13.1M TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 41,800 | $635K | 4.8% |
| 2 | $13.25 | 451,418 | $6.0M | 45.7% |
| 3 | $13.25 | 451,418 | $6.0M | 45.7% |
| 4 | $12.67 | 19,738 | $250K | 1.9% |
| 5 | $12.67 | 19,738 | $250K | 1.9% |
| Total | $13.31 avg | 984,112 |
| $13.1M |
| 100% |
| Filing → |
| TARS | BUY | 2020-10-20 | $4.0M | — | Filing → |